|
Lincoln Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
1250.36 Cr.
|
P/BV
|
1.65
|
Book Value (Rs.)
|
378.25
|
|
52 Week High/Low (Rs.)
|
770/440
|
FV/ML
|
10/1
|
P/E(X)
|
14.23
|
|
Bookclosure
|
12/09/2025
|
EPS (Rs.)
|
43.88
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| Diluted EPS (Rs.) | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| Cash EPS (Rs.) | 51.12 | 47.55 | 51.89 | 40.97 | 38.66 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 378.25 | 335.34 | 295.98 | 250.86 | 216.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 378.25 | 335.34 | 295.98 | 250.86 | 216.12 |
| Revenue From Operations / Share (Rs.) | 335.02 | 311.15 | 289.84 | 254.78 | 235.71 |
| PBDIT / Share (Rs.) | 65.47 | 61.89 | 67.07 | 55.76 | 52.66 |
| PBIT / Share (Rs.) | 58.23 | 55.45 | 61.76 | 51.18 | 48.62 |
| PBT / Share (Rs.) | 57.73 | 54.51 | 61.03 | 50.16 | 47.90 |
| Net Profit / Share (Rs.) | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| NP After MI And SOA / Share (Rs.) | 43.88 | 41.11 | 46.58 | 36.40 | 34.63 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 19.54 | 19.89 | 23.13 | 21.88 | 22.34 |
| PBIT Margin (%) | 17.38 | 17.82 | 21.30 | 20.08 | 20.62 |
| PBT Margin (%) | 17.23 | 17.51 | 21.05 | 19.68 | 20.32 |
| Net Profit Margin (%) | 13.09 | 13.21 | 16.07 | 14.28 | 14.69 |
| NP After MI And SOA Margin (%) | 13.09 | 13.21 | 16.07 | 14.28 | 14.69 |
| Return on Networth / Equity (%) | 11.60 | 12.25 | 15.73 | 14.50 | 16.02 |
| Return on Capital Employeed (%) | 14.96 | 16.07 | 20.34 | 19.89 | 21.94 |
| Return On Assets (%) | 9.87 | 10.33 | 13.32 | 12.41 | 12.97 |
| Total Debt / Equity (X) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.90 | 0.90 | 0.95 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 5.25 | 4.71 | 4.84 | 5.08 | 3.90 |
| Quick Ratio (X) | 4.53 | 3.97 | 4.00 | 4.11 | 3.10 |
| Inventory Turnover Ratio (X) | 8.45 | 8.00 | 7.89 | 2.48 | 2.66 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 4.37 | 3.22 | 4.12 | 4.32 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 3.78 | 2.89 | 3.66 | 3.87 |
| Earning Retention Ratio (%) | 0.00 | 95.63 | 96.78 | 95.88 | 95.68 |
| Cash Earning Retention Ratio (%) | 0.00 | 96.22 | 97.11 | 96.34 | 96.13 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 129.45 | 65.84 | 91.70 | 55.01 | 72.68 |
| Interest Coverage Ratio (Post Tax) (%) | 87.77 | 44.74 | 64.69 | 36.91 | 48.79 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 1102.14 | 1082.31 | 1159.77 | 646.08 | 574.49 |
| EV / Net Operating Revenue (X) | 1.64 | 1.74 | 2.00 | 1.27 | 1.22 |
| EV / EBITDA (X) | 8.40 | 8.73 | 8.63 | 5.79 | 5.45 |
| MarketCap / Net Operating Revenue (X) | 1.68 | 1.77 | 2.02 | 1.33 | 1.32 |
| Retention Ratios (%) | 0.00 | 95.62 | 96.77 | 95.87 | 95.67 |
| Price / BV (X) | 1.49 | 1.64 | 1.98 | 1.35 | 1.44 |
| Price / Net Operating Revenue (X) | 1.68 | 1.77 | 2.02 | 1.33 | 1.32 |
| EarningsYield | 0.07 | 0.07 | 0.07 | 0.10 | 0.11 |
